CEL-SCI Corp (CVM)

US · Healthcare · Biotechnology

$1.49+0.68%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-5.7M

EPS

$-0.47

Market cap

$26.7M

Forward P/E

23.0

P/B

2.47

Book value

$0.62

EPS (TTM)

$-1.67

52-week high

$10.83

52-week low

$0.89

50-day MA

$1.39

200-day MA

$3.28

Beta

0.62

Analysts rate CEL-SCI Corp a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $12.50.

Insiders

6.84%

Institutions

11.52%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for CEL-SCI Corp — free to start.

Data updated 2026-09-18.